These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19729021)

  • 21. Inflammation in dilated cardiomyopathy.
    Pankuweit S; Ruppert V; Maisch B
    Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Involvement of immune system in the pathogenesis of viral myocarditis].
    Ding GF
    Sheng Li Ke Xue Jin Zhan; 2002 Jan; 33(1):30-7. PubMed ID: 12001727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases in wound repair (review).
    Ravanti L; Kähäri VM
    Int J Mol Med; 2000 Oct; 6(4):391-407. PubMed ID: 10998429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of cardiac inflammation: molecular mechanisms.
    Pankuweit S; Portig I; Maisch B
    Herz; 2002 Nov; 27(7):669-76. PubMed ID: 12439638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases in renal development.
    Haas CS; Gleason B; Lin S; Tramonti G; Kanwar YS
    Connect Tissue Res; 2004; 45(2):73-85. PubMed ID: 15763922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs.
    Pearce WH; Shively VP
    Ann N Y Acad Sci; 2006 Nov; 1085():117-32. PubMed ID: 17182928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
    Matsumoto Y; Park IK; Kohyama K
    J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
    Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.
    Tomlinson ML; Garcia-Morales C; Abu-Elmagd M; Wheeler GN
    Mech Dev; 2008; 125(11-12):1059-70. PubMed ID: 18684398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases.
    Di Girolamo N; Chui J; Coroneo MT; Wakefield D
    Prog Retin Eye Res; 2004 Mar; 23(2):195-228. PubMed ID: 15094131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression].
    Ntayi C; Hornebeck W; Bernard P
    Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extracellular matrix metalloproteinases--perspectives of their use in medicine].
    Kotulska-Wolwender K; Larysz-Brysz M; Fus Z; Korczyńska I; Górka D; Lewin-Kowalik J
    Wiad Lek; 2002; 55(7-8):463-71. PubMed ID: 12428575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
    Kuhn H; Lawrenz T; Beer G
    Med Klin (Munich); 2005 Sep; 100(9):553-61. PubMed ID: 16170644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases and skeletal muscle: a brief review.
    Carmeli E; Moas M; Reznick AZ; Coleman R
    Muscle Nerve; 2004 Feb; 29(2):191-7. PubMed ID: 14755482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation.
    Van Lint P; Libert C
    J Leukoc Biol; 2007 Dec; 82(6):1375-81. PubMed ID: 17709402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.